---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-138321"
form_type: "8-K"
ticker: null
cik: "0001492674"
company_name: "T2 Biosystems, Inc."
filed_at: "2024-05-14T23:59:59+00:00"
generated_at: "2026-06-02T00:42:07.143662+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# T2 Biosystems amendments enable CRG debt-to-equity conversion; CRG now owns 69%

## Summary
- Removed beneficial ownership limitations on Series A and B Preferred Stock on May 9, 2024.
- CRG converted all preferred shares into 1,824,800 common shares, raising its ownership to ~69%.
- This follows prior conversions of $15M (May 2024) and $10M (July 2023) debt from CRG into equity.
- As a result, CRG now holds a controlling stake, significantly diluting other shareholders.

## SEC filing metadata
- accession: 0001193125-24-138321
- form_type: 8-K
- cik: 0001492674
- company_name: T2 Biosystems, Inc.
- filed_at: 2024-05-14T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 5.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1492674/000119312524138321/0001193125-24-138321-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1492674/000119312524138321/d836013d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-138321
- JSON: https://secwatch.observer/filing/0001193125-24-138321.json
- Plain text: https://secwatch.observer/filing/0001193125-24-138321.txt

## Key facts
- Governance Changes
  T2 Biosystems, Inc.: Amended and restated the Series A and Series B Certificates of Designation to remove beneficial ownership limitations on conversion of preferred stock into common stock (effective 2024-05-09).
  - Change: charter amendment
  - Effective: 2024-05-09
  source text: On May 9, 2024, the Company amended and restated each of the Series A Certificate of Designation and the Series B Certificate of Designation, in each case to remove the beneficial ownership limitations regarding the ability to convert the Series A Preferred Stock and Series B Preferred Stock, respectively, into shares of Common Stock without regarding to the beneficial ownership of the shareholder following such conversion.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1492674/000119312524138321/0001193125-24-138321-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.